ALPHA CAPITAL AKTIENGESELLSCHAFT 13D and 13G filings for Artelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-01-15 11:30 am Sale |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 52,267 4.990% |
-1,066![]() (-2.00%) |
Filing |
2020-10-22 1:18 pm Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 53,333 5.290% |
53,333![]() (New Position) |
Filing |